Siemens Healthineers Looking to Semi-Quantitative Assays for SARS-CoV-2 Serology Test Growth
Semi-quantitative SARS-CoV-2 serology tests enable users to measure levels of neutralizing antibodies, but tests need to be more comparable across manufacturers, Siemens said.
PATH is using the tool to benchmark RDTs for several diagnostic companies and help them understand if their products are meeting competitive performance standards.
PATH, SD Biosensor Collaborate on Malaria Diagnostic
The partners will further develop a test to guide clinical care of patients with Plasmodium vivax malaria who may also have G6PD deficiency.
PATH, Mologic to Develop Malaria Rapid Diagnostic Test
The test will expand the range of diagnostic options available to guide treatment of Plasmodium vivax malaria, which relapses.